ID18079A - Komposisi farmasi yang mengandung bahan pemercepat osteogenesis - Google Patents
Komposisi farmasi yang mengandung bahan pemercepat osteogenesisInfo
- Publication number
- ID18079A ID18079A IDP972959A ID972959A ID18079A ID 18079 A ID18079 A ID 18079A ID P972959 A IDP972959 A ID P972959A ID 972959 A ID972959 A ID 972959A ID 18079 A ID18079 A ID 18079A
- Authority
- ID
- Indonesia
- Prior art keywords
- pharmaceutical composition
- osteogenesis
- fastest
- osteoporosis
- derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22344396 | 1996-08-26 | ||
| JP9040897 | 1997-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID18079A true ID18079A (id) | 1998-02-26 |
Family
ID=26431895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDP972959A ID18079A (id) | 1996-08-26 | 1997-08-25 | Komposisi farmasi yang mengandung bahan pemercepat osteogenesis |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6190695B1 (id) |
| EP (1) | EP0949927B1 (id) |
| AT (1) | ATE226078T1 (id) |
| AU (1) | AU3868997A (id) |
| CA (1) | CA2264131A1 (id) |
| DE (1) | DE69716469T2 (id) |
| ES (1) | ES2181017T3 (id) |
| ID (1) | ID18079A (id) |
| WO (1) | WO1998008517A2 (id) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IS4518A (is) * | 1997-07-09 | 1999-01-10 | Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group | Nýtt lyfjaform fyrir bóluefni |
| AU4165699A (en) * | 1998-06-15 | 2000-01-05 | Takeda Chemical Industries Ltd. | Composition for treating cartilage disease |
| WO2000008018A1 (fr) | 1998-08-07 | 2000-02-17 | Takeda Chemical Industries, Ltd. | Derives de benzothiepine, leur procede de preparation et leurs utilisations |
| AR020158A1 (es) * | 1998-08-12 | 2002-04-10 | Takeda Chemical Industries Ltd | Mejorador del factor de induccion para la diferenciacion celular |
| WO2001010463A1 (fr) * | 1999-08-05 | 2001-02-15 | Takeda Chemical Industries, Ltd. | Pates a liberation prolongee d'un promoteur de l'osteogenese |
| WO2001097784A1 (fr) * | 2000-06-23 | 2001-12-27 | Takeda Chemical Industries, Ltd. | Procede de production de medicaments contenant des phospholipides |
| US7748388B2 (en) * | 2001-01-19 | 2010-07-06 | Hironori Yamamoto | Endoscopic injectable preparation |
| US6855332B2 (en) * | 2002-07-03 | 2005-02-15 | Lyfjathroun Hf. | Absorption promoting agent |
| US8158685B2 (en) * | 2004-07-02 | 2012-04-17 | Gregory Gene Steiner | Method for bone growth |
| DK1993559T3 (en) | 2006-02-03 | 2016-10-03 | Opko Renal Llc | Treatment of vitamin D deficiency and MALFUNCTION with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 |
| SI2679228T1 (en) * | 2006-06-21 | 2018-06-29 | Opko Ireland Global Holdings, Ltd. | THERAPY WITH THE USE OF VITAMIN D ADDITIONAL FIBER AND HORMON RESISTANCE OF VITAMIN D |
| CA2683514C (en) | 2007-04-25 | 2019-07-09 | Proventiv Therapeutics, Llc | Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease |
| JP5647516B2 (ja) * | 2007-04-25 | 2014-12-24 | シトクロマ インコーポレイテッド | ビタミンｄ療法のための方法および化合物 |
| DK2148684T3 (da) * | 2007-04-25 | 2013-04-22 | Cytochroma Inc | Fremgangsmåde til behandling af vitamin D-insufficiens og -deficiens |
| SI2148661T1 (sl) | 2007-04-25 | 2013-04-30 | Cytochroma Inc. | Nadzorovano oralno sproščanje sestavkov, ki vsebujejo spojino vitamina D in voskasti naosilec |
| ES2593356T3 (es) | 2008-04-02 | 2016-12-07 | Opko Ireland Global Holdings, Ltd. | Métodos, composiciones, usos y kits útiles para la deficiencia de la vitamina D y trastornos relacionados |
| RS60087B1 (sr) | 2010-03-29 | 2020-05-29 | Opko Ireland Global Holdings Ltd | Postupci i kompozicije za snižavanje nivoa paratireoidnog hormona |
| KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 ｄ 방출 제형 |
| US10220047B2 (en) | 2014-08-07 | 2019-03-05 | Opko Ireland Global Holdings, Ltd. | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor |
| US11173168B2 (en) | 2016-03-28 | 2021-11-16 | Eirgen Pharma Ltd. | Methods of treating vitamin D insufficiency in chronic kidney disease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4906475A (en) * | 1988-02-16 | 1990-03-06 | Paco Pharmaceutical Services | Estradiol transdermal delivery system |
| DK656789A (da) | 1988-12-28 | 1990-06-29 | Takeda Chemical Industries Ltd | Benzoheterocykliske forbindelser |
| ATE203020T1 (de) * | 1990-05-30 | 2001-07-15 | Takeda Chemical Industries Ltd | Schwefel enthaltende heterocyclische verbindungen |
| WO1994023740A1 (en) * | 1993-04-22 | 1994-10-27 | Celtrix Pharmaceuticals, Inc. | Conjugates of growth factor and bone resorption inhibitor |
| JP3319625B2 (ja) * | 1993-05-12 | 2002-09-03 | ホーユー株式会社 | 速崩壊性生薬製剤 |
| TW403757B (en) * | 1994-12-28 | 2000-09-01 | Takeda Chemical Industries Ltd | Optically active benzothiepin derivative, its preparation and use |
| AR003001A1 (es) * | 1995-06-05 | 1998-05-27 | Takeda Chemical Industries Ltd | Composicion farmaceutica estimuladora de la osteogenesis. |
-
1997
- 1997-08-25 CA CA002264131A patent/CA2264131A1/en not_active Abandoned
- 1997-08-25 ID IDP972959A patent/ID18079A/id unknown
- 1997-08-25 EP EP97935871A patent/EP0949927B1/en not_active Expired - Lifetime
- 1997-08-25 DE DE69716469T patent/DE69716469T2/de not_active Expired - Lifetime
- 1997-08-25 AT AT97935871T patent/ATE226078T1/de not_active IP Right Cessation
- 1997-08-25 ES ES97935871T patent/ES2181017T3/es not_active Expired - Lifetime
- 1997-08-25 WO PCT/JP1997/002941 patent/WO1998008517A2/en active IP Right Grant
- 1997-08-25 AU AU38689/97A patent/AU3868997A/en not_active Abandoned
-
1999
- 1999-02-09 US US09/246,851 patent/US6190695B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU3868997A (en) | 1998-03-19 |
| ES2181017T3 (es) | 2003-02-16 |
| DE69716469T2 (de) | 2003-02-20 |
| EP0949927A2 (en) | 1999-10-20 |
| DE69716469D1 (de) | 2002-11-21 |
| EP0949927B1 (en) | 2002-10-16 |
| ATE226078T1 (de) | 2002-11-15 |
| WO1998008517A2 (en) | 1998-03-05 |
| US6190695B1 (en) | 2001-02-20 |
| WO1998008517A3 (en) | 1998-05-07 |
| CA2264131A1 (en) | 1998-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID18079A (id) | Komposisi farmasi yang mengandung bahan pemercepat osteogenesis | |
| SE9901272D0 (sv) | New improved formulation | |
| ATE136221T1 (de) | Osteo-induktive pharmazeutische formulierungen | |
| TW366342B (en) | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss | |
| DE60224284D1 (de) | Stabile formulierung von modifiziertem glp-1 | |
| GT199700009AA (es) | Terapia combinada para la osteoporosis | |
| BR0314356A (pt) | Formulações de liberação retardada para administração oral de um agente terapêutico polipetìdeo e métodos utilizando as mesmas | |
| BE2015C026I2 (en) | 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens | |
| YU59092A (sh) | Formulacije aerosola koji ne sadrže hlorofluorougljenična jedinjenja | |
| MY118151A (en) | Pharmaceutical formulations containing voriconazole. | |
| CY1109212T1 (el) | Φαρμακευτικες συνθεσεις για την θεραπεια του ασθμα | |
| BR0207961A (pt) | Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas | |
| SE9704186D0 (sv) | New composition of matter | |
| DK0679393T3 (da) | Pharmaceutisk præparat til behandling af osteoporose indeholdende xanthohumol | |
| BR9708114A (pt) | Análogos xantona para o tratamento de doenças infecciosas. | |
| TR200101103T2 (tr) | CGMP PDE-İnhibitörü içeren kontrollu serbest bırakılan farmasötik formülasyonlar | |
| ATE212846T1 (de) | Bisphosphonat und anti-resorption agentien, enthaltende zusammensetzungen zur hemmung der knochenschwund | |
| ATE395071T1 (de) | Pharmazeutische zubereitungen zur angiogenese- therapie | |
| BR0008509A (pt) | Composição farmacêutica oral estabilizada contendo iodeto e iodato e método | |
| DE50005529D1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
| BR0212857A (pt) | Formulações e uso destas | |
| YU16399A (sh) | ) UPOTREBA INHIBITOR H +, K+ - ATP- aze I FARMACEUTSKA FORMULACIJA ZA SIMULTANU, SEPARATNU ILI SEKVENCIJALNU UPOTREBU, KOJA SADRZI INHIBITOR H +, K+-ATP- aze I GLUKOKORTIKOID INHIBITOR H +, K+- ATP- aze | |
| DE69907926D1 (de) | 1,2,4-triazol-3-thion verbindungen | |
| ATE464878T1 (de) | Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl | |
| HUP0300402A3 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them |